Nifty Pharma Today: Index Falls 1.45% in Closing Bell

Quick sector takeaways

• Nifty Pharma ended 1.45% lower, down 393.80 points at 26,792.65 versus the previous close of 27,186.45.
• The index traded between 27,004.40 and 26,683.25 during the session, with its closing level remaining closer to the day’s low than its high.
• Market breadth was negative: 13 of 20 displayed pharma stocks declined, while seven advanced and none were unchanged.
• JB Chemicals & Pharmaceuticals, Divi’s Laboratories and Sun Pharmaceutical Industries were among the notable drags, while Dr. Reddy’s Laboratories, Abbott India and Granules India rose. Watch whether the next session brings broader participation among gainers.

As of 1 September 2026 at 4:15:00 PM IST, this end-of-session update tracks nifty pharma today through the index’s actual close, intraday range and stock-level breadth.

Nifty Pharma today: closing bell recap

Nifty Pharma finished the session at 26,792.65, declining 393.80 points, or 1.45%, from 27,186.45. The sector index opened at 27,004.40, which was also its intraday high, and subsequently moved lower to touch 26,683.25. It recovered modestly from that low by the close but remained below both the opening level and the previous close.

The closing pattern puts the focus on the difference between a few advancing names and the broader negative participation across pharma stocks. The index-level decline was accompanied by losses in several prominent stocks, while a smaller set of gainers offered selective counter-moves. This was therefore a weak closing session for the sector index, rather than a uniform move across every listed pharma name.

Price snapshot

The intraday range was 321.15 points between the high and low. From the opening level of 27,004.40, the index closed 211.75 points lower. Its close was 109.40 points above the day’s low, an observation that highlights the late-session position within the day’s range without assigning a cause to the move.

Sector ranking

Nifty Pharma was the top losing sector index in the configured sector-index set on 1 September. Its 1.45% decline was marginally steeper than Nifty Mid Select’s 1.43% fall and exceeded the declines recorded by Nifty Auto, Nifty Financial Services and Nifty Bank. Nifty Metal was nearly flat, while Nifty IT and Nifty FMCG ended higher.

That ranking gives the pharma move additional context: the sector was the weakest performer within the configured set for the session. It does not, by itself, explain why the index fell; it simply establishes the relative scale of the closing decline against the other tracked indices.

Constituent breadth

The breadth reading was clearly tilted towards declines. Of the 20 displayed stocks in the index, 13 fell and seven gained, leaving no unchanged stocks. The advance-decline ratio stood at 0.54, meaning that for every advancing stock there were close to two declining stocks.

Negative breadth aligned with the index’s 1.45% fall. However, the presence of seven gainers shows that the session retained pockets of strength. Dr. Reddy’s Laboratories, Abbott India, Granules India, Cipla, Natco Pharma, Ipca Laboratories and Zydus Lifesciences closed higher even as the sector index finished lower.

Heavyweights versus broader participation

The supplied heavyweight and active-stock lists place the spotlight on Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Within this group, Sun Pharmaceutical Industries fell 2.81%, Divi’s Laboratories declined 3.19% and Torrent Pharmaceuticals lost 1.98%. Cipla added 0.98%, while Dr. Reddy’s Laboratories rose 1.44%.

This split is important for reading the sector close. Three names in the supplied heavyweight group ended lower, including two of the larger percentage fallers, while two ended higher. The same names appear in the supplied active-stock set, making their closing moves useful reference points for tracking how the sector’s larger and closely followed stocks behaved alongside the broader breadth data.

Key Nifty Pharma stocks

Biggest positive movers

Dr. Reddy’s Laboratories led the supplied gainers with a 1.44% rise to ₹1,171. Abbott India followed with a 1.10% advance to ₹26,135, while Granules India gained 1.05% to ₹837.20. Cipla rose 0.98% to ₹1,423 and Natco Pharma added 0.92% to ₹849.20.

These advances demonstrate that stock-specific strength was present despite the lower sector close. Dr. Reddy’s Laboratories reached an intraday high of ₹1,179.90, Abbott India touched ₹26,215 and Granules India recorded a high of ₹840.90. These are session observations, not explanations for their respective moves.

Biggest negative movers

JB Chemicals & Pharmaceuticals led the supplied losers, falling 3.87% to ₹2,408.90 after trading between ₹2,380 and ₹2,525.50. Divi’s Laboratories declined 3.19% to ₹9,165, while Sun Pharmaceutical Industries fell 2.81% to ₹1,929. Laurus Labs lost 2.79% to ₹1,861.60 and Ajanta Pharma dropped 2.70% to ₹3,504.80.

Biocon also featured among the larger declines, down 2.66% to ₹401.05. The concentration of declines across these names was consistent with the sector’s negative breadth and top-loser ranking for the day.

Stocks to watch next session

For the next session, market participants can track Divi’s Laboratories, Sun Pharmaceutical Industries, JB Chemicals & Pharmaceuticals, Dr. Reddy’s Laboratories, Abbott India and Cipla. This group captures both the sharper closing declines and the key positive movers from the session.

Divi’s Laboratories closed at ₹9,165 after a 3.19% decline, while Sun Pharmaceutical Industries ended at ₹1,929, down 2.81%. In contrast, Dr. Reddy’s Laboratories and Cipla closed higher. Watching whether these opposing moves broaden or reverse may offer a clearer read on participation within the pharma pack.

The constructive case

The constructive evidence lies in the seven advancing stocks and the gains in Dr. Reddy’s Laboratories, Abbott India, Granules India, Cipla, Natco Pharma, Ipca Laboratories and Zydus Lifesciences. Among the supplied heavyweight names, Dr. Reddy’s Laboratories and Cipla closed higher, showing that strength was not limited to a single stock.

Nifty Pharma also closed 109.40 points above its intraday low of 26,683.25. That leaves the index off the session bottom, even though it ended decisively lower on the day. Any future assessment should continue to distinguish such observable price positioning from an assumed market catalyst.

The cautious case

The cautious case is centred on the 1.45% index fall, the 13-to-seven decline-to-advance breadth split and the fact that the index opened at its high before moving lower. The close of 26,792.65 remained below the previous close of 27,186.45 and below the day’s opening level.

Several closely watched names also ended in the red. Divi’s Laboratories, Sun Pharmaceutical Industries and Torrent Pharmaceuticals declined within the supplied heavyweight set, while JB Chemicals & Pharmaceuticals was the largest percentage loser among the highlighted stocks. The next session’s breadth will be important in determining whether the pressure remains widespread or becomes more selective.

Univest Insights

The closing picture for nifty pharma today is one of sector-wide pressure with meaningful stock-level divergence. The index’s rank as the top loser among the configured sector indices reflects the scale of the move, while breadth confirms that declining stocks outnumbered gainers.

The intraday path was also notable: the index opened at 27,004.40, its high for the day, declined to 26,683.25 and settled at 26,792.65. This sequence frames the session as one where the closing level remained within the lower portion of the day’s range.

At the stock level, the contrast between the losses in JB Chemicals & Pharmaceuticals, Divi’s Laboratories and Sun Pharmaceutical Industries and the gains in Dr. Reddy’s Laboratories, Abbott India and Cipla provides the most useful read-through. Investors can follow the Univest Market View for broader market context alongside this sector dashboard.

For traders and investors, the key signal to watch is…

Published on 1 September 2026 at 4:18 PM IST

Frequently asked questions

What was Nifty Pharma’s closing level on 1 September 2026?

Nifty Pharma closed at 26,792.65, down 393.80 points or 1.45% from the previous close of 27,186.45.

What were the day high and day low for Nifty Pharma?

The index recorded a day high of 27,004.40 and a day low of 26,683.25.

Why was Nifty Pharma the top losing sector index?

Nifty Pharma fell 1.45%, the largest decline among the configured sector indices tracked in this update.

How was the breadth within Nifty Pharma?

Among 20 displayed stocks, 13 declined and seven advanced, with no unchanged stocks.

Which stocks were the biggest gainers in Nifty Pharma today?

Dr. Reddy’s Laboratories gained 1.44%, followed by Abbott India at 1.10% and Granules India at 1.05%.

Which stocks were the biggest losers in Nifty Pharma today?

JB Chemicals & Pharmaceuticals fell 3.87%, Divi’s Laboratories declined 3.19%, and Sun Pharmaceutical Industries lost 2.81%.